Valeant Posts 340B Overcharging Public Notice

by Admin | July 5, 2016 3:09 pm

July 5, 2016—Valeant Pharmaceuticals, which is under congressional and Justice Department investigation for its prescription drug pricing, says it might have overcharged healthcare providers in the 340B program for three products between Aug. 4 and Sept. 8, 2015 and will issue the affected providers wholesaler credits.  

You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register[1].    Already registered? Click here to login[2]. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)

Endnotes:
  1. Click here to register: https://secure.340bhealth.org/340Binformed/Subscribe.aspx
  2. Click here to login: http://340binformed.org/reader-login/

Source URL: https://340binformed.org/2016/07/valeant-posts-340b-overcharging-public-notice/

Copyright ©2026 340binformed.org unless otherwise noted.